Praluent Alirocumab — Blue Cross Blue Shield Of Montana
5 indications indexed for this drug.
- Clinical Atherosclerotic Cardiovascular Disease AscvdView coverage criteria
- Elevated 10 Year Ascvd Risk 20 29 30 39 40 With Ldl C AboveView coverage criteria
- Heterozygous Familial Hypercholesterolemia HefhView coverage criteria
- Homozygous Familial Hypercholesterolemia HofhView coverage criteria
- Primary HyperlipidemiaView coverage criteria